Commentary: AG Blumenthal keeps IDSA Honest
In 2008, the Attorney General began an investigation into the IDSA Guidelines for Lyme disease. Numerous conflicts of interests were questioned between Insurance Companies, Pharmaceutical Companies and the IDSA Guideline’s panelists.
At the moment, the IDSA guidelines are so skewed in the Insurance companies’ favor it is often difficult for a patient to receive any treatment for Lyme. Additionally, the stringent guidelines pressure doctors who treat Lyme patients. The guidelines enable insurance companies and state medical boards to threaten doctor’s whom they say over prescribe antibiotics.
The results of this investigation are critical to the Lyme community because the IDSA guidelines are generally the litmus test as to whether or not an insurance company will pay for a patient’s Lyme treatment.
On the 1st of February, the Attorney General’s office sent a letter to the IDSA concerned about how the IDSA Guideline review process was not complying with the settlement agreement. Essentially, the IDSA was stacking the voters of the review process much like they had done when initially writing the guidelines.
It is unconceivable to think that an organization so empowered for the well being of the American people can be so dismissive of their well-being.
The pressure put on the IDSA by the Attorney General and others demonstrates the greatness of our country and people to correct the impurities in the system.
Visit Lisa Chamoff’s article in the Greenwich Time “AG chides Lyme panel for not following settlement agreement” for more information: http://www.greenwichtime.com/local/article/AG-chides-Lyme-panel-for-not-following-settlement-360055.php